Most of the local brokerage houses maintain ‘buy’ or ‘accumulate’ rating on the Axis Bank on expectation of sustained return on assets (ROA) expansion over the next 24 months to drive a multiple expansion as asset quality distractions recede.
Axis Bank reported the loss was on account of accelerated stressed asset recognition, precipitated by new RBI guidelines on Resolution of Stressed Assets.
“The bank reported slippages of Rs 165 billion (18.1% of opening loans), leading to elevated income reversals and high loan loss provisions, thereby impacting profits. In FY19ii, Axis Bank plans to recognise residual stress in 1HFY19ii and then proceed to more normalised operations in 2HFY19ii. It also aims to revamp its corporate banking vertical. The accelerated stress recognition and high provisions, thereon, is a positive,” IIFL Institutional Equities said in result review.
“The rebound in return on equity (RoE) would be sharp, but would be contingent on precise execution and a supportive operating environment. At depressed multiples and bottomed-out earnings; the risk reward is highly favourable,” the brokerage firm said with recommend BUY on the stock with 12 month target price of Rs 620.
“The bank has articulated an execution strategy for FY19 that hinges primarily on normalizing credit risk - however, the management commentary suggests a lack of confidence, which is unnerving,” SBICAP Securities said in result review.
Asset quality normalization during 1HFY19 is a key catalyst for the conversation to meaningfully shift to operating vectors such as incremental loan mix shift, well-diversified fee engines and recent-vintage corporate portfolio. As asset quality distractions recede, we expect sustained ROA expansion over the next 24 months to drive a multiple expansion, it added. The brokerage firm maintains ‘buy’ rating on the stock with a revised price target of Rs 730.
Analysts at Emkay Global Financial Services expect Axis Bank to return to earnings normalcy in FY20E with profitability touching 1.1% in RoA terms.
The RoE nevertheless shall remain in low teens. We prefer to value AXSB on 1-year forward P/ABV and assign a multiple of 2.5 times to the same, the brokerage firms said with ‘accumulate’ rating on the stock with 12 month target price of Rs 560.
At 10:50 am; the stock was trading 4.5% higher at Rs 517 on the BSE, as compared to 0.74% rise in the S&P BSE Sensex. The trading volumes on the counter jumped more than three-fold with a combined 26.9 million shares changed hands on the NSE and BSE so far.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)